🕵️ Elite Pharmaceuticals Inc /NV/ ($ELTP)
SEC insider & ownership activity, last 12 months · CIK 1053369 · every row links its SEC filing
Over the last 12 months insiders sold $761K with no open-market buying against it. Plassche Douglas sold $499K in discretionary trades (Oct). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $761K (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Plassche Douglas | 0 | – | 1 | $499K | Oct 2, 2025 |
| Elite Pharmaceuticals Inc /NV/ | 0 | – | 1 | $262K | Aug 22, 2025 |
5%+ holders
No current 5%+ beneficial-ownership positions on file.
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Plassche Douglas | $555K | Aug 22, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Jun 29, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 29, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 23, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 15, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 29, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 2, 2026 | filing ↗ |
| Earnings (2.02) | Feb 17, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 17, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 11, 2026 | filing ↗ |
| Earnings (2.02) | Nov 14, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 14, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Earnings (2.02) | Aug 14, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 14, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 8, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 8, 2025 | filing ↗ |